Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

913 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Population Pharmacokinetic Model of Piperacillin in Critically Ill Patients and Describing Interethnic Variation Using External Validation.
Sanches C, Alves GCS, Farkas A, da Silva SD, de Castro WV, Chequer FMD, Beraldi-Magalhães F, Magalhães IRDS, Baldoni AO, Chatfield MD, Lipman J, Roberts JA, Parker SL. Sanches C, et al. Among authors: farkas a. Antibiotics (Basel). 2022 Mar 24;11(4):434. doi: 10.3390/antibiotics11040434. Antibiotics (Basel). 2022. PMID: 35453185 Free PMC article.
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions.
Roberts JA, Abdul-Aziz MH, Lipman J, Mouton JW, Vinks AA, Felton TW, Hope WW, Farkas A, Neely MN, Schentag JJ, Drusano G, Frey OR, Theuretzbacher U, Kuti JL; International Society of Anti-Infective Pharmacology and the Pharmacokinetics and Pharmacodynamics Study Group of the European Society of Clinical Microbiology and Infectious Diseases. Roberts JA, et al. Among authors: farkas a. Lancet Infect Dis. 2014 Jun;14(6):498-509. doi: 10.1016/S1473-3099(14)70036-2. Epub 2014 Apr 24. Lancet Infect Dis. 2014. PMID: 24768475 Free PMC article. Review.
Impact of the MIC of piperacillin/tazobactam on the outcome for patients with bacteraemia due to Enterobacteriaceae: the Bacteraemia-MIC project.
Delgado-Valverde M, Torres E, Valiente-Mendez A, Almirante B, Gómez-Zorrilla S, Borrell N, Corzo JE, Gurgui M, Almela M, García-Álvarez L, Fontecoba-Sánchez MC, Martínez-Martínez L, Cantón R, Praena J, Causse M, Gutiérrez-Gutiérrez B, Roberts JA, Farkas A, Pascual Á, Rodríguez-Baño J; REIPI/GEIH-SEIMC BACTERAEMIA-MIC Group. Delgado-Valverde M, et al. Among authors: farkas a. J Antimicrob Chemother. 2016 Feb;71(2):521-30. doi: 10.1093/jac/dkv362. Epub 2015 Nov 3. J Antimicrob Chemother. 2016. PMID: 26538507 Free article.
Population pharmacokinetics and evaluation of the predictive performance of pharmacokinetic models in critically ill patients receiving continuous infusion meropenem: a comparison of eight pharmacokinetic models.
Dhaese SAM, Farkas A, Colin P, Lipman J, Stove V, Verstraete AG, Roberts JA, De Waele JJ. Dhaese SAM, et al. Among authors: farkas a. J Antimicrob Chemother. 2019 Feb 1;74(2):432-441. doi: 10.1093/jac/dky434. J Antimicrob Chemother. 2019. PMID: 30376103
Corrigendum to "Early target attainment of continuous infusion piperacillin/tazobactam and meropenem in critically ill patients: A prospective observational study" [Journal of Critical Care 52 (2019) 75-79].
Dhaese SAM, Thooft ADJ, Farkas A, Lipman J, Verstraete AG, Stove V, Roberts JA, De Waele JJ. Dhaese SAM, et al. Among authors: farkas a. J Crit Care. 2020 Apr;56:325. doi: 10.1016/j.jcrc.2019.09.020. Epub 2019 Nov 15. J Crit Care. 2020. PMID: 31740024 No abstract available.
913 results